Skip to content

Evommune EVMN Gross Profit

Gross Profit at other companies

Pfizer logo
PfizerPFE
$10.9B+0.3%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$79.1M+108%
Perrigo Company logo
Perrigo CompanyPRGO
$325.5M-17.0%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$396.79M-7.9%

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total debt$2.0M
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Calculated from Evommune ’s reported figures.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's gross profit?
Evommune (EVMN) reported gross profit of $961.13K in Q1 2026.
How has Evommune 's gross profit changed year-over-year?
Evommune 's gross profit increased by 10.9% year-over-year, from $866.76K to $961.13K.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.